<DOC>
	<DOCNO>NCT02321228</DOCNO>
	<brief_summary>The purpose study determine whether innovative preventive strategy , consist early salpingectomy upon completion childbearing delay oophorectomy beyond current guideline age , improve menopause-related quality life without significantly increase ovarian cancer incidence comparison current standard salpingo-oophorectomy female BRCA1/2 mutation carrier .</brief_summary>
	<brief_title>Early Salpingectomy ( Tubectomy ) With Delayed Oophorectomy BRCA1/2 Gene Mutation Carriers</brief_title>
	<detailed_description>Eligible woman choose innovative standard risk-reducing option .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Premenopausal woman document BRCA1 and/or BRCA2 germline mutation Age 2540 year BRCA1 mutation carrier , 2545 year BRCA2 Childbearing complete Presence least one fallopian tube Participants may personal history nonovarian malignancy Postmenopausal status ( natural menopause due ( cancer ) treatment ) Wish second stage oophorectomy within two year salpingectomy ( clear enrollment ) Legally incapable Prior bilateral salpingectomy A personal history ovarian , fallopian tube peritoneal cancer Evidence malignant disease enrollment Treatment malignant disease enrollment Inability read speak Dutch BRCA mutation carrier opt salpingectomy want postpone oophorectomy beyond guideline age undergo similar followup contribute 510 inclusion need</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Salpingectomy</keyword>
	<keyword>Delayed oophorectomy</keyword>
	<keyword>Salpingo-oophorectomy</keyword>
	<keyword>Quality life</keyword>
	<keyword>Ovarian cancer</keyword>
	<keyword>BRCA</keyword>
</DOC>